Advertisement

Inflammopharmacology

, Volume 27, Issue 6, pp 1143–1153 | Cite as

Neuroprotective and anti-inflammatory effects of isoliquiritigenin in kainic acid-induced epileptic rats via the TLR4/MYD88 signaling pathway

  • Xiaobo Zhu
  • Jiankun Liu
  • Ou Chen
  • Jiang Xue
  • Shanying Huang
  • Weiwei ZhuEmail author
  • Yibiao WangEmail author
Original Article
  • 118 Downloads

Abstract

Epileptogenesis is a complex pathological process that occurs after an initial brain injury and involves a series of molecular events. Isoliquiritigenin (ISL), a flavonoid in licorice, is reported to have anti-inflammatory and antioxidant effects in various experimental models, but its specific roles and molecular mechanisms in the epileptogenic process following kainic acid (KA) treatment remain unclear. The purpose of this study was to explore the effects of ISL pretreatment in KA-induced epileptic rats and the underlying mechanisms. Our findings show that ISL pretreatment significantly attenuated the KA-induced expression of ionized calcium‐binding adapter molecule 1 (IBα1)-labeled microglia (F(3, 20) = 97.29, p < 0.01, ηp2 = 0.94) and glial fibrillary acidic protein (GFAP)-positive astrocytes (F(3, 20) = 72.48, p < 0.01, ηp2 = 0.92), and the release of inflammatory mediators, such as TNF-α (F(3, 20) = 133.14, p < 0.01, ηp2 = 0.95), IL-1β, and C–C motif chemokine ligand 3 (CCL3). ISL pretreatment given before KA also significantly prevented apoptotic neuronal injury by upregulating the activities of superoxide dismutase and glutathione peroxidase. It also significantly suppressed the protein levels of Toll-like receptor 4 (TLR4) (F(3, 20) = 63.23, p < 0.01, ηp2 = 0.91) and its downstream molecules, myeloid differentiation primary response 88 (MYD88), phosphorylated (p-)IκBα, and p-NF-κB. Blocking TLR4/MYD88 signaling also attenuated KA-induced neuroinflammation and neuronal damage in the hippocampus. Overall, our study demonstrates that ISL pretreatment plays neuroprotective and anti-inflammatory roles in KA-induced epileptogenesis, which may be mediated by the TLR4/MYD88 signaling pathway.

Keywords

Isoliquiritigenin Neuroprotection Toll-like receptor 4 Kainic acid Epileptogenesis Rat 

Notes

Acknowledgements

This work was funded by the Basic Research for Natural Science Project of Shandong University (No. 2015TS014) and China Scholarship Council (201706225013). We also thank International Science Editing (https://www.internationalscienceediting.com) for editing this manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Candelario-Jalil E, Al-Dalain SM, Castillo R, Martínez G, Fernández OS (2001) Selective vulnerability to kainate-induced oxidative damage in different rat brain regions. J Appl Toxicol 21:403–407CrossRefGoogle Scholar
  2. Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro MA, Lizasoain I (2007) Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 115:1599–1608CrossRefGoogle Scholar
  3. Chu K, Jung KH, Lee ST, Kim JH, Kang KM, Kim HK, Lim JS, Park HK, Kim M, Lee SK, Roh JK (2008) Erythropoietin reduces epileptogenic processes following status epilepticus. Epilepsia 49:1723–1732CrossRefGoogle Scholar
  4. Du F, Gesang Q, Cao J, Qian M, Ma L, Wu D, Yu H (2016) Isoliquiritigenin attenuates atherogenesis in apolipoprotein E-deficient mice. Int J Mol Sci 17:1932CrossRefGoogle Scholar
  5. Funakoshi-Tago M, Ohsawa K, Ishikawa T, Nakamura F, Ueda F, Narukawa Y, Kiuchi F, Tamura H, Tago K, Kasahara T (2016) Inhibitory effects of flavonoids extracted from Nepalese propolis on the LPS signaling pathway. Int Immunopharmacol 40:550–560CrossRefGoogle Scholar
  6. Honda H, Nagai Y, Matsunaga T, Saitoh S, Akashi-Takamura S, Hayashi H, Fujii I, Miyake K, Muraguchi A, Takatsu K (2012) Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner. J Leukoc Biol 91:967–976CrossRefGoogle Scholar
  7. Jeon JP, Buono RJ, Han BG, Jang EY, Kim SC, Yang CH, Hwang M (2008) Proteomic and behavioral analysis of response to isoliquiritigenin in brains of acute cocaine treated rats. J Proteome Res 7:5094–5102CrossRefGoogle Scholar
  8. Korff CM, Dale RC (2017) The immune system in pediatric seizures and epilepsies. Pediatrics 140:e20163534CrossRefGoogle Scholar
  9. Larochelle A, Bellavance MA, Rivest S (2015) Role of adaptor protein MyD88 in TLR-mediated preconditioning and neuroprotection after acute excitotoxicity. Brain Behav Immun 46:221–231CrossRefGoogle Scholar
  10. Lee MJ, Yang CH, Jeon JP, Hwang M (2009) Protective effects of isoliquiritigenin against methamphetamine-induced neurotoxicity in mice. J Pharmacol Sci 111:216–220CrossRefGoogle Scholar
  11. Lee SH, Kim JY, Seo GS, Kim YC, Sohn DH (2009) Isoliquiritigenin, from Dalbergia odorifera, up-regulates anti-inflammatory heme oxygenase-1 expression in RAW264.7 macrophages. Inflamm Res 58:257–262CrossRefGoogle Scholar
  12. Lee HK, Yang EJ, Kim JY, Song KS, Seong YH (2012) Inhibitory effects of glycyrrhizae radix and its active component, isoliquiritigenin, on Aβ (25–35)-induced neurotoxicity in cultured rat cortical neurons. Arch Pharm Res 35:897–904CrossRefGoogle Scholar
  13. Li Z, Li B, Zhu X, Yin P, Liu J, Huang S, Sun R (2013) Neuroprotective effects of anti-high-mobility group box 1 antibody in juvenile rat hippocampus after kainic acid-induced status epilepticus. Neuroreport 24:785–790CrossRefGoogle Scholar
  14. Ma X, Fang F, Song M, Ma S (2015) The effect of isoliquiritigenin on learning and memory impairments induced by high-fat diet via inhibiting TNF-α/JNK/IRS signaling. Biochem Biophys Res Commun 464:1090–1095CrossRefGoogle Scholar
  15. Mogami S, Sadakane C, Nahata M, Mizuhara Y, Yamada C, Hattori T, Takeda H (2016) CRF receptor 1 antagonism and brain distribution of active components contribute to the ameliorative effect of rikkunshito on stress-induced anorexia. Sci Rep 6:27516CrossRefGoogle Scholar
  16. Park SJ, Song HY, Youn HS (2009) Suppression of the TRIF-dependent signaling pathway of toll-like receptors by isoliquiritigenin in RAW264.7 macrophages. Mol Cells 28:365–368CrossRefGoogle Scholar
  17. Park SJ, Youn HS (2010) Suppression of homodimerization of toll-like receptor 4 by isoliquiritigenin. Phytochemistry 71:1736–1740CrossRefGoogle Scholar
  18. Paxinos G, Watson C (2005) The rat brain in stereotaxic coordinates, 5th edn. Elsevier Academic Press, BurlingtonGoogle Scholar
  19. Peng F, Du Q, Peng C, Wang N, Tang H, Xie X, Shen J, Chen J (2015) A review: the pharmacology of isoliquiritigenin. Phytother Res 29:969–977CrossRefGoogle Scholar
  20. Qi M, Zheng L, Qi Y, Han X, Xu Y, Xu L, Yin L, Wang C, Zhao Y, Sun H, Liu K, Peng J (2015) Dioscin attenuates renal ischemia/reperfusion injury by inhibiting the TLR4/MyD88 signaling pathway via up-regulation of HSP70. Pharmacol Res 100:341–352CrossRefGoogle Scholar
  21. Rahimifard M, Maqbool F, Moeini-Nodeh S, Niaz K, Abdollahi M, Braidy N, Nabavi SM, Nabavi SF (2017) Targeting the TLR4 signaling pathway by polyphenols: a novel therapeutic strategy for neuroinflammation. Ageing Res Rev 36:11–19CrossRefGoogle Scholar
  22. Rakhade SN, Jensen FE (2009) Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Neurol 5:380–391CrossRefGoogle Scholar
  23. Rizzi M, Perego C, Aliprandi M, Richichi C, Ravizza T, Colella D, Velískŏvá J, Moshé SL, De Simoni MG, Vezzani A (2003) Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development. Neurobiol Dis 14:494–503CrossRefGoogle Scholar
  24. Shin EJ, Ko KH, Kim WK, Chae JS, Yen TP, Kim HJ, Wie MB, Kim HC (2008) Role of glutathione peroxidase in the ontogeny of hippocampal oxidative stress and kainate seizure sensitivity in the genetically epilepsy-prone rats. Neurochem Int 52:1134–1147CrossRefGoogle Scholar
  25. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335–376CrossRefGoogle Scholar
  26. Thiyagarajan P, Chandrasekaran CV, Deepak HB, Agarwal A (2011) Modulation of lipopolysaccharide-induced pro-inflammatory mediators by an extract of Glycyrrhiza glabra and its phytoconstituents. Inflammopharmacology 19:235–241CrossRefGoogle Scholar
  27. Vezzani A, Granata T (2005) Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46:1724–1743CrossRefGoogle Scholar
  28. Wang N, Han X, Liu H, Zhao T, Li J, Feng Y, Mi X, Zhang Y, Chen Y, Wang X (2017) Myeloid differentiation factor 88 is up-regulated in epileptic brain and contributes to experimental seizures in rats. Exp Neurol 295:23–35CrossRefGoogle Scholar
  29. Watanabe Y, Nagai Y, Honda H, Okamoto N, Yamamoto S, Hamashima T, Ishii Y, Tanaka M, Suganami T, Sasahara M, Miyake K, Takatsu K (2016) Isoliquiritigenin attenuates adipose tissue inflammation in vitro and adipose tissue fibrosis through inhibition of innate immune responses in mice. Sci Rep 6:23097CrossRefGoogle Scholar
  30. Yang EJ, Min JS, Ku HY, Choi HS, Park MK, Kim MK, Song KS, Lee DS (2012) Isoliquiritigenin isolated from Glycyrrhiza uralensis protects neuronal cells against glutamate-induced mitochondrial dysfunction. Biochem Biophys Res Commun 421:658–664CrossRefGoogle Scholar
  31. Zeng J, Chen Y, Ding R, Feng L, Fu Z, Yang S, Deng X, Xie Z, Zheng S (2017) Isoliquiritigenin alleviates early brain injury after experimental intracerebral hemorrhage via suppressing ROS- and/or NF-κB-mediated NLRP3 inflammasome activation by promoting Nrf2 antioxidant pathway. J Neuroinflammation 14:119CrossRefGoogle Scholar
  32. Zhan C, Yang J (2006) Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Pharmacol Res 53:303–309CrossRefGoogle Scholar
  33. Zhang F, Dong H, Lv T, Jin K, Jin Y, Zhang X, Jiang J (2018) Moderate hypothermia inhibits microglial activation after traumatic brain injury by modulating autophagy/apoptosis and the MyD88-dependent TLR4 signaling pathway. J Neuroinflammation 15:273CrossRefGoogle Scholar
  34. Zhu XB, Wang YB, Chen O, Zhang DQ, Zhang ZH, Cao AH, Huang SY, Sun RP (2012) Characterization of the expression of macrophage inflammatory protein-1α (MIP-1α) and C-C chemokine receptor 5 (CCR34) after kainic acid-induced status epilepticus (SE) in juvenile rats. Neuropathol Appl Neurobiol 38:602–616CrossRefGoogle Scholar
  35. Zou P, Ji HM, Zhao JW, Ding XM, Zhen ZG, Zhang X, Nie XQ, Xue LX (2018) Protective effect of isoliquiritigenin against cerebral injury in septic mice via attenuation of NF-κB. Inflammopharmacology. https://doi.org/10.1007/s10787-018-0503-z CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of PediatricsThe Second Hospital of Shandong UniversityJinanChina
  2. 2.Department of OphthalmologyThe Second People’s Hospital of Jinan CityJinanChina
  3. 3.Nursing SchoolShandong UniversityJinanChina
  4. 4.The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public HealthShandong UniversityJinanChina
  5. 5.Department of PediatricsJinan Central Hospital Affiliated To Shandong UniversityJinanChina
  6. 6.Department of PediatricsThe Second Hospital of Shandong UniversityJinanChina

Personalised recommendations